Improved Patient Outcomes

By integrating AI with Cognitive Behavioral Therapy (CBT) and mindfulness techniques, Abriella Care offers a scalable, accessible solution for improving patient outcomes.

Our research demonstrates the potential of AI in expanding mental health services, reducing clinician workloads, and providing continuous support for patients.

Prescribed by a GP or registered clinician, Abriella is only available to patients through healthcare professionals. Unlike mainstream apps/solutions, Abriella is tailored specifically for clinical use, ensuring that it is introduced as part of a structured treatment plan.

This personalised approach, backed by mental health experts, ensures effective, evidence-based care for those who need it most.

Rapid Response

Abriella enables access to evidence-based talking therapies, initiating talking therapies within 5 days of diagnosis by a GP.

Reduced Waiting Times

Abriella helps reduce patient waiting times by delivering timely interventions, easing demand on clinical resources.

Increased Therapist Capacity

Abriella supports therapists by delivering our evidence-backed 8 week program, allowing clinicians to focus on more complex cases.

Continuous Support

Patients receive continuous, AI-driven support between therapy sessions, promoting ongoing mental well-being.

Portable Device

With Advanced Curated AI, tailored for patients diagnosed with anxiety, low mood, and depression.

Augmented Therapy

Abriella is designed to augment traditional therapy rather than replace.

Key Features

Abriella offers evidence-based therapeutic solutions designed to improve mental health outcomes and increase therapist capacity.

8-Week MBCT Program

Our advanced, evidence-backed 8-week Mindfulness-Based Cognitive Therapy (MBCT) program is designed to reduce stress and improve patient outcomes through structured therapeutic interventions.
MBCT Program

Mood Tracking and Analysis

Abriella provides comprehensive mood tracking and analysis, giving both patients and therapists valuable insights into mental health progress over time, helping to inform treatment decisions.
Mood Tracking

Voice-Activated Journaling

Our voice-activated journaling feature allows patients to log their thoughts and feelings hands-free, offering a convenient way to track emotional states and therapeutic milestones.
Voice Journaling

Journal & Mood Summarisation for Therapists

Abriella’s AI-powered journal summarisation tool provides therapists with concise summaries of patient entries, improving their capacity by saving an estimated 3 hours of therapy time per patient.
Journal Summarization

Advanced Technology Overview

Explore the innovative technology that powers Abriella, our AI-driven therapeutic assistant designed to enhance mental health care delivery.
  • NLP & NLU
  • Bluetooth Voice Activation
  • Personalised Care
  • Enhanced Security
  • Real-Time Feedback
NLP & NLU

NLP & NLU

Abriella’s advanced Natural Language Processing (NLP) and Natural Language Understanding (NLU) systems feature unique intent recognition and probability engines, enabling precise interpretation of patient input for personalised responses.

Abriella's internal software and algorithms are ring-fenced, ensuring robust security and reliability. The use of a large language model (LLM) is limited to less than 2%, serving only as a fallback mechanism to maintain consistency and reliability in patient care.
Bluetooth Voice Activation

Bluetooth Voice Activation

Abriella is fully voice-activated and compatible with Android & Apple devices, allowing seamless use without the need of your smartphone for interaction, connect your faviourite headphones for even further Privacy, this approach provides flexibility for patient home use.
Personlised Care

Personalised Care

Upon completion of the initial 8-week program, Abriella generates a comprehensive journal summary and mood analysis. This data is reviewed by the therapist, who can then tailor further treatment to the patient's needs. Abriella can autonomously deliver the adjusted therapeutic interventions, ensuring ongoing personalised care without the need for constant clinician input.

Clinical Safety and Compliance

As a prescribed mental health device, Abriella will conform to clinical safety standards set by NHS Digital:

  • DCB0160: Clinical Risk Management in the Deployment and Use of Health IT Systems.
  • DCB0129: Clinical Risk Management in the Manufacture of Health IT Systems.

These standards ensure effective application of clinical risk management in the deployment, use, maintenance, or decommissioning of Health IT Systems within healthcare.

Safety Review and Certification

  • ORCHA Review: Abriella will undergo a rigorous digital health safety review by the Organisation for the Review of Care and Health Apps (ORCHA).


  • Medical Device Certification: Application for Class 2A medical device certification is envisioned, ensuring the highest safety and efficacy standards.
Real-Time Feedback

Real-Time Feedback

Abriella provides real-time feedback based on patient responses, offering instant therapeutic support to maintain engagement and ensure timely interventions.

Companion App

Our Companion App is only available to service users, and is designed for connecting to the device only. Abriella is unique in that it is all voice activated once connected

Work With Us

We would love to hear from researchers, professionals, those in tech. If you feel this project is of interest to you or your team, please get in touch. We'd love to hear from you. Get in touch